Executive Leadership
Acrotech’s leadership team is comprised of a diverse and experienced group of professionals, who have enjoyed success prior to becoming part of Acrotech, and have been integral to Acrotech’s growth within the US market. As a team, they embody Acrotech’s culture focused around the care of Acrotech’s business, people, and customers.
Executive Management Team
Ashish Anvekar
President
Ashish is a Hands-on Sales, Marketing and Business Development professional with 20+ years of pharmaceutical experience. Formerly he has been responsible for building profitable business from the ground up by creative partnerships, acquisitions and organic R&D initiatives.
Kiran Nagabandhi
Vice President, Finance
Kiran has 23+ years of experience in Pharmaceutical Industry in multi GAAP Accounting (USGAAP, India GAAP and IFRS) and having experience in wide spectrum of finance activities encompassing Strategy, Acquisitions, In-Licensing & Out-Licensing, Shared Service operations, Financial Reporting, FP&A, Controllership, ERP implementations, Fund management, Cost planning, Compliance, Internal Controls and Audit. Proven track record in maintaining surprise free operations. Part of Key strategy team and Pricing committee.
Kiran is responsible for Finance and Commercial Supply Chain functions of Acrotech Biopharma, Branded Division of Aurobindo Pharma USA Inc. Prior to Joining Acrotech, Kiran held numerous finance roles served as Controller for AuroMedics & AuroHealth (pharma), Head of finance for Lonza (Life Sciences), General Manager Finance for BioGenex (Medical devices & Re-agents), Associate Vice President with Genpact / GlaxoSmithKline (Pharma), Sr. Manager for Dr. Reddy’s Laboratories (Pharmaceuticals).
Paul Mingmongkol
Senior Director, Marketing
Paul joined the Acrotech team in October 2019 where he leads the Marketing Team’s efforts across the Acrotech hematology/oncology portfolio. Paul has over 20 years of commercial pharmaceutical experience in sales, sales management, training, and marketing. His marketing experience includes multiple therapeutic areas including 5 years in oncology. He has worked in both biotech and big pharma environments. Prior to joining Acrotech, Paul was at Bristol-Myers Squibb (BMS). At BMS Paul led the US Professional marketing efforts for Renal Transplant and later moved to the US Immuno-Oncology Commercial Biomarkers team. Paul earned his MBA from Cornell University and his BS from the University of Illinois, Urbana-Champaign.
